Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer (Q43244627)
Jump to navigation
Jump to search
scientific article published in February 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer |
scientific article published in February 2010 |
Statements
Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer (English)
Peter Galettis
Mohammad H Pourgholami
Michael Szwajcer
Winston Liauw
Jonathan Seef
1 February 2010